FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · reporting period

Sienna Biopharmaceuticals, Inc.: net_income

One fact, its scope and the complete path back to the official record.

Period: 2018-04-01 – 2018-06-30Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/f7bb98f7-69e3-4620-bef4-09c3b6d7c27f

Reported value

$-20.239M{"amount": -20239000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"}
Entity
Sienna Biopharmaceuticals, Inc.
Metric
net_income
Period
2018-04-01 – 2018-06-30
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001193125-18-243629 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T17:03:26.023341+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001656328/net-income/2018-06-30 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.